Bozitinib
| CAS No. | 1440964-89-5 | Cat. No. | BCP34901 |
| Name | Bozitinib | ||
| Synonyms | PLB-1001; PLB1001; PLB 1001; CBT-101; CBT101; CBT 101; | ||
| Formula | C20H15F3N8 | M. Wt | 424.39 |
| Description | Bozitinib is a highly selective c-MET kinase inhibitor with blood-brain barrier permeability. Bozitinib (PLB-1001) is a ATP-competitive small-molecule inhibitor, binds to the conventional ATP-binding pocket of the tyrosine kinase superfamily. | ||
| Pathways | Angiogenesis/Protein Tyrosine Kinase | ||
| Targets | c Met | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.